Conclusions
NSSI
Results of this trial suggest that a 12-week, therapist-guided, IERITA delivered adjunctive to TAU is efficacious in the treatment of NSSI and related factors compared with TAU only. Findings that week-to-week improvements in emotion dysregulation were associated with week-to-week reductions in NSSI frequency during IERITA provide preliminary support for the proposed mechanism of change in IERITA.